Module 4 Pharmacology Flashcards
Releaser, except
A. Tyramine
B. Ephedrine
C. Angiotensin II
D. Aldosterone
Aldosterone
The metal which is the causative agent of Minamata’s disease wherein the villagers manifested CNS toxicity
A. Lead
B. Mercury
C. Arsenic
D. Platinum
Mercury
Noyes-Whittney equation determines
A. Particle size measurement
B. Actual drug solubility
C. Dissolution constant
D. Dissolution rate
Dissolution rate
Major pathway for elimination of many drugs and metabolites from the body
A. Tears
B. Sweat
C. Urine
D. Feces
Urine
What is the common undesirable effect of methyldopa
A. Vertigo
B. Depression
C. Sedation
D. Hemolytic anemia
Sedation
Creatinine clearance is used as a measure of
A. Renal excretion
B. Glomerular filtration rate
C. Active tubular secretion
D. Passive tubular secretion
Glomerular filtration rate
Difference in bioavailability aren most frequently observed with drugs administered by which of the following route
A. Subcutaneous
B. Intravenous
C. Oral
D. Sublingual
Oral
The intensity of pharmacologic action of a drug is most dependent on the
A. Concentration of the drug at the receptor site
B. Elimination half-life of the drug
C. Onset time of the drug after oral administration
D. Minimum effective concentration of drug in the plasma
Concentration the drug at the receptor site
Target proteins to which a drug molecule can bind are
A. Receptors
B. Ion channel
C. Carrier
D. All of the above
All of the above
Which tissue has the greatest capacity to biotransform drugs
A. Brain
B. Kidney
C. Liver
D. Lungs
Liver
The biological half-life of a drug
A. Is a constant physical property of a drug
B. Is a constant chemical property of a drug
C. Is the time for one half of the therapeutic activity to be lost
D. Depends entirely on the route of administration
Is the time for one half of the therapeutic activity to be lost
Main mechanism of most drug absorption in the GIT is
A. Active transport
B. Filtration
C. Endocytosis
D. Passive diffusion
Passive diffusion
Which if the following factors influence renal clearance
A. Age
B. Disease
C. Both a and b
D. None of the above
Both a and b
What is the reason of complicated penetration of some drugs through the blood brain barrier
A. High lipid solubility
B. Meningitis
C. Absence of pores in the brain capillary endothelium
D. High endocytosis degree in the brain capillary
Absence of pore in the brain capillary endothelium
Also known as drug delivery system
A. Drug distribution
B. Drug liberation
C. Drug administration
D. Dosage form
Dosage form
A decrease in the therapeutic index of a drug
A. Increases the potential of a drug to become toxic
B. Increases the efficacy of a drug
C. Decrease the lethality of a drug
D. All of the above
Increases the potential of a drug to become toxic
For the calculation of the volume of distribution one must take account of
A. Concentration of substance in the plasma
B. Concentration of substance in the urine
C. Therapeutic index of the drug action
D. Daily dose of drug
Concentration of substance in the plasma
An inactive (or much less active) substance which biotransformed to active drug in the body
A. Dosage form
B. Modified release
C. Drug product
D. Prodrug
Prodrug
Biotransformation of medicinal substance results in
A. Faster urinary excretion
B. Slower urinary excretion
C. Easier distribution
D. Higher binding to membrane
Faster urinary excretion
During ovulation, peak plasma concentration of which of the following hormone(s) will be reached
I. Luteinizing hormone (LH)
II. Follicle stimulating hormone (FSH)
III. Progesterone
A. I only
B. III only
C. I & II only
D. II & III only
I & II only
Half -life doesn’t depend on
A. Biotransformation
B. Time of drug absorption
C. Concentration drug in the plasma
D. Rate of drug elimination
Time of drug absorption
Elimination is expressed as follow
A. Rate of renal tubular reabsorption
B. Clearance speed of some volume of blood from substance
C. Time required to decrease the amount of drug in the plasma by one-half
D. Clearance of an organism from xenobiotic
Clearance of an organism from xenobiotic
Stimulation of beta-adrenereceptor involves generation of secondary messenger known as
A. IP3
B. cGMP
C. DAG
D. cAMP
cAMP
Toxins found in castor bean plant
A. Pyrethrin
B. Ergometrine
C. Ricin
D. Uroshiol
Ricin
Elimination rate constant is defined by which of the following parameter
A. Rate of absorption
B. Maximal concentration of a substance in plasma
C. Highest single dose
D. Half-life
Half-life
A type of absorption mechanism which is characterized by engulfing vesicle
A. Convective transport
B. Pinocytosis
C. Ion-pair transport
D. Passive diffusion
Pinocytosis
Alteration of protein synthesis such as disruption of membrane protein channel and interference on signaling and loss of enzyme function is an example of which mechanism
A. Lipid peroxidation
B. Target molecule dysfunction
C. Non targeted toxicity
D. Formation of neoantigen
Target molecule dysfunction
Which of the following is a phase II drug metabolizing reaction
A. Acetylation
B. Hydrolysis
C. Reduction
D. Deamination
Acetylation
A physical process by which a weak acid becomes less water soluble and more lipid soluble at low pH
A. Distribution
B. First Pass
C. Protonation
D. Elimination
Protonation
An absorption process is not involved when a drug by which one of the following route of administration
A. Oral
B. Intravenous
C. Intramuscular
D. Rectal
Intravenous
Regarding termination of drug action, which of the following statements is true
A. Drug must be excreted from the body to eliminate the action
B. Metabolism of drug always abolishes their pharmacologic activity
C. Metabolism of drug always increases their water solubility
D. Hepatic metabolism and renal excretion are two of the most important mechanism involved
Hepatic metabolism and renal excretion are two of the most important mechanism involved
The term “biological availability” or “bioavailability” refers to the relative amount of drug that reaches the
A. Small intestine
B. Stomach
C. Systemic circulation
D. Liver
Systemic circulation
The AUC can be described as being a
I. Theoretic value
II. Measure of drug concentration-time curve
III. Value with units of weigh and time/volume
A. I & II
B. II & III
C. I & III
D. I, II & III
I, II & III
The “F” value for a drug product is ideally compared to its
A. Absolute bioavailability
B. Dosing rate
C. Clearance rate
D. Relative bioavailability
Absolute bioavailability
The biological half-life of a drug that is eliminated by first order kinetics is represented mathematically by
A. 1/k
B. Log k
C. 0.693/k
D. 2.303 / k
0.693/k
The following beta-blocker have local anesthetic activity
I. Pindolol
II. Carvedilol
III. Metoprolol
IV. Esmolol
A. I , II
B. II, III
C. I, III
D. I, IV
I, III
Difference in bioavailability are most frequently observed with drugs administered by which of the following route
A. Subcutaneous
B. Intravenous
C. Oral
D. Sublingual
Oral
Two different oral formulations containing the same dose of the same drug having equal areas under their respective serum concentration – time curve
A. Deliver the same total amount of drug to the body and are therefore bioequivalent
B. Deliver the same total amount of drug to the body but are not necessarily bioequivalent
C. Are bioequivalent
D. Bioequivalent if they both meet the USP disintegration standard
Deliver the same total amount of drug to the body but are not necessarily bioequivalent
If an oral capsule formulation of drug A produces a serum concentration – time curve having the same area under the curve as that produced by an equivalent dose of drug A given IV, it can generally be conducted that
A. The IV route is preferred over the oral route
B. Capsule formulation is essentially completely absorbed
C. The drug is very rapidly absorbed
D. All oral dosage forms of drug A will be bioequivalent
Capsule formulation is essentially completely absorbed
Gastric emptying time is slowed by all of the following, except
A. Vigorous exercise
B. Fatty food
C. Hot meals
D. Hunger
Hunger